Kenya - English - Pharmacy and Poisons Board

glaxosmithkline pharmaceutical kenya limited p.o. box 78392 - 00507, nairobi, kenya - virus polio type 1, strain lsc, 2ab; virus polio… - oral suspension - virus polio type 1, strain lsc, 2ab… - poliomyelitis oral bivalent live attenuated

Kenya - English - Pharmacy and Poisons Board

china sinopharm international corporation… 4, huixindongjie, chaoyang district, beijing - virus strain polio virus seed (sabin strain) type… - oral drops - each dose of 2 drops (0.1ml) contains polio virus… - poliomyelitis oral bivalent live attenuated

Ireland - English - HPRA (Health Products Regulatory Authority)

ashford pharmaceuticals limited - poliomyelitis vaccine -

Kenya - English - Pharmacy and Poisons Board

sanofi pasteur s.a. 2 avenue pont pasteur 69007 lyon - poliovirus# type 1 mahoney strain (inactivated) … - suspension for injection - one dose (0.5 ml) contains: poliovirus# type 1… - viral vaccines: poliomyelitis vaccines

Philippines - English - FDA (Food And Drug Administration)

n/a; importer: faberco life sciences inc.; distributor: faberco life sciences inc. - inactivated poliomyelitis vaccine (types 1, 2, and 3) - suspension for injection (im/sc) - formulation: each dose (0.5 ml) contains: inactivated poliovirus type 1, mahoney strain*40 d antigen units inactivated poliovirus type 2, mef-1 strain* 8 d antigen units inactivated poliovirus type 3, saukett strain* 32 d antigen units *cultivated on vero cells

Canada - English - Health Canada

aventis pasteur limited - poliovirus vaccine live orl-trival human type-1; poliovirus vaccine live orl-trival human type-2; poliovirus vaccine live orl-trival human type-3 - suspension - 1000000unit; 100000unit; 300000unit - poliovirus vaccine live orl-trival human type-1 1000000unit; poliovirus vaccine live orl-trival human type-2 100000unit; poliovirus vaccine live orl-trival human type-3 300000unit - vaccines

Canada - English - Health Canada

aventis pasteur limited - poliovirus vaccine live orl-trival human type-1; poliovirus vaccine live orl-trival human type-2; poliovirus vaccine live orl-trival human type-3 - solution - 1000000unit; 100000unit; 150000unit - poliovirus vaccine live orl-trival human type-1 1000000unit; poliovirus vaccine live orl-trival human type-2 100000unit; poliovirus vaccine live orl-trival human type-3 150000unit - vaccines

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe s.a. - poliovirus type 1 (inactivated) 40 d-antigen u/0,5 ml; poliovirus type 3 (inactivated) 32 d-antigen u/0,5 ml; poliovirus type 2 (inactivated) 8 d-antigen u/0,5 ml - suspension for injection - poliomyelitis virus - poliomyelitis, trivalent, inactivated, whole virus

Kenya - English - Pharmacy and Poisons Board

sanofi pasteur s.a. 2, avenue pont pasteur 69007 lyon france - poliomyelitis virus type 1, ls c2ab strain,… - suspension and effervescent granules for oral - each 0.1-ml dose (2 drops) contains:poliomyelitis… - viral vaccines: poliomyelitis vaccines

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - suspension for injection - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of three years onwards. the administration of boostrix polio should be based on official recommendations.